Literature DB >> 974794

Distribution of 3H-alpha-MSH in rat brain.

A J Kastin, C Nissen, K Nikolics, K Medzihradszky, D H Coy, I Teplan, A V Schally.   

Abstract

Radioactive synthetic alpha-MSH, prepared by selective tritiation of its dibromo-L-tyrosine-derivative, was injected into the carotid artery of intact, hypophysectomized or pinealectomized rats. More radioactivity was found in the occipital cortex, cerebellum, and pons-medulla than in most other brain parts of rats decapitated 15 sec and, to a less significant extent, 30 min after injection. Part of this radioactivity behaved like alpha-MSH in several identification procedures. After administration of 3H-tyrosine, the least radioactivity was consistently found in the pons-medulla. Large amounts of radioactivity after 3H-alpha-MSH were found in the pituitary and, particularly in the hypophysectomized rats, in the pineal. The half-time disappearance of the first component of radioactivity from the blood of each group of rats injected with tritiated-alpha-MSH was no more than 2.5 minutes, a time considerably shorter than the behavioral and EEG effects of this pituitary hormone on visual attention.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 974794     DOI: 10.1016/0361-9230(76)90045-9

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  10 in total

Review 1.  Cytokine signaling modulates blood-brain barrier function.

Authors:  Weihong Pan; Kirsten P Stone; Hung Hsuchou; Vamshi K Manda; Yan Zhang; Abba J Kastin
Journal:  Curr Pharm Des       Date:  2011-11       Impact factor: 3.116

Review 2.  Concepts for biologically active peptides.

Authors:  Abba J Kastin; Weihong Pan
Journal:  Curr Pharm Des       Date:  2010-10       Impact factor: 3.116

Review 3.  Delivering peptides to the central nervous system: dilemmas and strategies.

Authors:  W A Banks; A J Kastin; C M Barrera
Journal:  Pharm Res       Date:  1991-11       Impact factor: 4.200

Review 4.  Design of peptide and peptidomimetic ligands with novel pharmacological activity profiles.

Authors:  Victor J Hruby; Minying Cai
Journal:  Annu Rev Pharmacol Toxicol       Date:  2013       Impact factor: 13.820

5.  Low permeability of the blood-brain barrier to nanomolar concentrations of immunoreactive alpha-melanotropin.

Authors:  J F Wilson
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

6.  Neuropeptide regulation of interleukin-1 activities. Capacity of alpha-melanocyte stimulating hormone to inhibit interleukin-1-inducible responses in vivo and in vitro exhibits target cell selectivity.

Authors:  B A Robertson; L C Gahring; R A Daynes
Journal:  Inflammation       Date:  1986-12       Impact factor: 4.092

Review 7.  Peptides and the blood-brain barrier.

Authors:  William A Banks
Journal:  Peptides       Date:  2015-03-21       Impact factor: 3.750

8.  Effect of serotonin on prolactin- and MSH-secreting cells in the eel. Comparison with the effect of 5-hydroxytryptophan.

Authors:  M Olivereau; J Olivereau
Journal:  Cell Tissue Res       Date:  1979-02-28       Impact factor: 5.249

9.  Naloxone prevents the analgesic action of alpha-MSH in mice.

Authors:  T Ohkubo; M Shibata; H Takahashi; S Naruse
Journal:  Experientia       Date:  1985-05-15

Review 10.  Behavioral effects of ACTH and MSH peptides.

Authors:  A Bertolini; G L Gessa
Journal:  J Endocrinol Invest       Date:  1981 Apr-Jun       Impact factor: 4.256

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.